期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (2)
Background/Aims: The new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a wide spectrum of effects, including acute kidney injury......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (4)
Introduction: Increased permeability of the renal capillaries is a common consequence of sepsis-associated acute kidney injury. Vascular endothelial (......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (4)
Introduction: In diabetic nephropathy (DN), mitochondrial dysfunction and leakage of mitochondrial DNA (mtDNA) are caused by the downregulation of sup......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (11)
Introduction: The immune senescence marked by inflation of memory T cell is established in end-stage renal disease (ESRD) patients with peritoneal dia......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (7)
Background: China has the largest absolute burden of hypertension (HTN) in the world. Gut dysbiosis may be a potentially modifiable risk factor for HT......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (6)
Background: Naringenin, a natural resource-derived flavanone, exhibits a plethora of pharmacological properties. The present study aimed to investigat......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (2)
Introduction: Diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease. Dysregulation of circulating miRNAs has been reported......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (4)
Objective: Indoxyl sulfate (IS) is a protein-bound uremic toxin that is associated with cardiovascular events and mortality in hemodialysis (HD) patie......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (5)
Background: Post-transplant hypomagnesemia is commonly observed among patients prescribed calcineurin inhibitor (CNIs). Methods: We conducted a retros......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (8)
Background: Chronic kidney disease (CKD) is one of the most common diseases in adult age, and it is typical of older adults. Recent data suggest that ......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (12)
IntroductionThere have been few studies comparing younger and older adults with membranous nephropathy. The objective of this study was to compare you......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (11)
Introduction: At present, the mortality rate of clear cell renal cell carcinoma (ccRCC) remains high. The development of biomarkers is conducive to th......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (4)
Background: The phase III clinical trial of the nonsteroidal mineralocorticoid receptor antagonist finerenone (BAY 94-8862) has been completed, aiming......
期刊： KIDNEY & BLOOD PRESSURE RESEARCH, 2022; 47 (7)
Introduction: Since the pandemic of COVID-19 started from December 2019, remarkable numbers of infections and deaths associated with COVID-19 have bee......
